Cancer researchers are turning to mathematical models to help answer important clinical questions, and a new article illustrates how the technique may answer questions about Herceptin resistance.
Cancer researchers are turning to mathematical models to help answer important clinical questions, and a new article illustrates how the technique may answer questions about Herceptin resistance.